Hemagen Diagnostics, Inc.
HMGN
Rank in Stocks
#34878
Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in... Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase proteins. Its comprehensive human diagnostic portfolio also encompasses Universal IFA components, various supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialized assays covering conditions such as Chagas, acute phase proteins, and cytokines. For the veterinary market, Hemagen Diagnostics provides diagnostic equipment, reagents, consumables, accessories, and electrodes crucial for chemistry, hematology, and electrolyte analysis. The company reaches a diverse customer base, including laboratories, hospitals, and blood banks, through both direct sales and an extensive distribution network. Established in 1985, Hemagen Diagnostics maintains its headquarters in Columbia, Maryland.
Share Price
$0.0002
Last synced: 2026-11-06
Market Cap
$3.10K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Hemagen Diagnostics, Inc. (HMGN)
Category
Healthcare
Operating Margin for Hemagen Diagnostics, Inc. (HMGN)
Operating Margin as of November 2026 TTM: -10.83%
According to Hemagen Diagnostics, Inc.'s latest financial reports, its current operating margin (TTM) is -10.83%. At the end of 2012 the company had an operating margin of -10.83%.
Operating Margin history for Hemagen Diagnostics, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -10.83% | 0.00% |
| 2012 | -10.83% | 17.85% |
| 2011 | -9.19% | -303.32% |
| 2010 | 4.52% | -170.19% |
| 2009 | -6.44% | -448.11% |
| 2008 | 1.85% | -152.26% |
| 2007 | -3.54% | 2.31% |
| 2006 | -3.46% | -70.02% |
| 2005 | -11.54% | 51.44% |
| 2004 | -7.62% | -363.67% |
| 2003 | 2.89% | -140.93% |
| 2002 | -7.06% | 194.17% |
| 2001 | -2.40% | -93.79% |
| 2000 | -38.63% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -103.56% |
US
|
|
| -149.01% | -86.24% |
US
|
|
| 25.57% | -102.36% |
AU
|
|
| 31.23% | -102.88% |
BE
|
|
| 29.35% | -102.71% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Hemagen Diagnostics, Inc.'s operating margin
What is Hemagen Diagnostics, Inc.'s operating margin?
Hemagen Diagnostics, Inc.'s operating margin is -10.83%, as of Nov 2026.
What was Hemagen Diagnostics, Inc.'s operating margin in 2012?
In 2012, Hemagen Diagnostics, Inc.'s operating margin was -10.83%, compared with -9.19% in 2011.
How has Hemagen Diagnostics, Inc.'s operating margin changed since 2007?
From 2007 to 2012, Hemagen Diagnostics, Inc.'s operating margin was highest in 2010 (4.52%) and lowest in 2012 (-10.83%).
How does Hemagen Diagnostics, Inc.'s operating margin compare with similar companies?
Hemagen Diagnostics, Inc.'s operating margin (-10.83%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.